The March of Transcatheter Aortic Valve Replacement Therapy—US Food and Drug Administration Perspectives on Device Approval for Patients at Low Surgical Risk-Reference-Cited by-同舟云学术

The March of Transcatheter Aortic Valve Replacement Therapy—US Food and Drug Administration Perspectives on Device Approval for Patients at Low Surgical Risk

Published:2020-01-01 Issue:1 Volume:5 Page:5
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Wu Changfu¹,Vasseur Bernard¹,Maisel William²

Affiliation:

1. Division of Circulatory Support, Structural and Vascular Devices, Office of Cardiovascular Devices, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland

2. Office of Product Evaluation and Quality, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2754763/jamacardiology_wu_2019_vp_190016.pdf

Reference3 articles.

1. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.;Mack;N Engl J Med,2019

2. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.;Popma;N Engl J Med,2019

3. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.;Nishimura;J Am Coll Cardiol,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table;European Heart Journal;2024-02-16

2. The Interventional Imager;Interventional Cardiology Clinics;2024-01

3. Cardiac implantable electronic device procedure history as the most important predictor of poor 2-year survival after transcatheter aortic valve replacement;Kardiologia Polska;2023-06-29

4. Aortic stenosis may not be fatal anymore in wealthy societies: but what about the rest of the world?;Heart;2023-05-26

5. Mortality trends of aortic stenosis in high-income countries from 2000 to 2020;Heart;2023-05-19